{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:48:24Z","timestamp":1767772104797},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1993,12,1]],"date-time":"1993-12-01T00:00:00Z","timestamp":754704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1993,12]]},"DOI":"10.1007\/bf03348960","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T06:47:19Z","timestamp":1396594039000},"page":"925-932","source":"Crossref","is-referenced-by-count":19,"title":["Hirsutism and the effectiveness of spironolactone in its management"],"prefix":"10.1007","volume":"16","author":[{"given":"G. R.","family":"McMullen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Van Herle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"BF03348960_CR1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.1973.03220280028007","volume":"225","author":"DJ Greenblatt","year":"1973","unstructured":"Greenblatt D.J., Koch-Weser J.O. Adverse reactions to spironolactone-A report from the Boston collaborative drug surveillance program. JAMA 225: 40, 1973.","journal-title":"JAMA"},{"key":"BF03348960_CR2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.1963.73700230005018","volume":"184","author":"NM Mann","year":"1963","unstructured":"Mann N.M. Gynecomastia during therapy with spironolactone. JAMA 184: 778, 1963.","journal-title":"JAMA"},{"key":"BF03348960_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.1965.03090020077026","volume":"193","author":"E Clark","year":"1965","unstructured":"Clark E. Spironolactone therapy and gynecomastia. JAMA 193: 175, 1965.","journal-title":"JAMA"},{"key":"BF03348960_CR4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-69-4-685","volume":"69","author":"RF Spark","year":"1968","unstructured":"Spark R.F., Melby J.C. Aldosteronism in hypertension: The spironolactone response test. Ann. Intern. Med. 69: 685, 1968.","journal-title":"Ann. Intern. Med."},{"key":"BF03348960_CR5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archinte.1972.03650060047008","volume":"130","author":"EV Adlin","year":"1972","unstructured":"Adlin E.V., Marks A.D., Channick B.J. Spironolactone and hydrochlorothiazide in essential hypertension. Arch. Intern. Med. 130: 855, 1972.","journal-title":"Arch. Intern. Med."},{"key":"BF03348960_CR6","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1001\/jama.1970.03170120058015","volume":"211","author":"JI Levitt","year":"1970","unstructured":"Levitt J.I. Spironolactone therapy and amenorrhea. JAMA 211: 2014, 1970.","journal-title":"JAMA"},{"key":"BF03348960_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/jid.1964.137","volume":"43","author":"EL Jones","year":"1964","unstructured":"Jones E.L., Woodbury L. The effect of anti-androgens on the response of rat preputial glands to testosterone. J. Invest. Dermatol. 43: 165, 1964.","journal-title":"J. Invest. Dermatol."},{"key":"BF03348960_CR8","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1210\/jcem-26-12-1394","volume":"26","author":"A Zarate","year":"1966","unstructured":"Zarate A., Mahesh V.B, Greenblatt R.B. Effect of an antiandrogen, 17\u03b1-Methyl-\u03b2-nortestosterone, on acne and hirsutism. J. Clin. Endocrinol. Metab. 26: 1394, 1966.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348960_CR9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0022-4731(83)90223-6","volume":"19","author":"J Hammerstein","year":"1983","unstructured":"Hammerstein J., Moltz L., Schwartz U. Antiandrogens in the treatment of acne and hirsutism. J. Steroid Biochem. 19: 591, 1983.","journal-title":"J. Steroid Biochem."},{"key":"BF03348960_CR10","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1210\/endo-94-6-1628","volume":"94","author":"RH Menard","year":"1974","unstructured":"Menard R.H., Stripp B., Gillette J.R. Spironolactone and testicular cytochrome P-450. Decreased testosterone formation in several species and changes in hepatic drug metabolism. Endocrinology 94: 1628, 1974.","journal-title":"Endocrinology"},{"key":"BF03348960_CR11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0003-9861(76)90277-0","volume":"173","author":"RH Menard","year":"1976","unstructured":"Menard R.H., Bartter F.C., Gillette J.R. Spironolactone and cytochrome P-450: Impairment of steroid 21-hydroxylation in the adrenal cortex. Arch. Biochem. Biophys. 173: 395, 1976.","journal-title":"Arch. Biochem. Biophys."},{"key":"BF03348960_CR12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/jcem-41-4-777","volume":"410","author":"B Stripp","year":"1975","unstructured":"Stripp B., Taylor A.A., Bartter F.C., Gillette J.R., Loriaux D.L., Easley R., Menard R.H. Effect of spironolactone on sex hormones in man. J. Clin. Endocrinol. Metab. 410: 777, 1975.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348960_CR13","first-page":"279A","volume":"24","author":"AA Taylor","year":"1976","unstructured":"Taylor A.A., Mitchell J.R., Rollins D.E., Snodgrass W.R., Bartter F.C. Effect of spironolactone(s) on adrenal and gonadal steroids in man [abstract]. Clin. Res. 24: 279A, 1976.","journal-title":"Clin. Res."},{"key":"BF03348960_CR14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.1982.03320340049034","volume":"247","author":"DC Cumming","year":"1982","unstructured":"Cumming D.C., Yang J.C. Rebar R.W., Yen S.S.C. Treatment of hirsutism with spironolactone. JAMA 247: 1295, 1982.","journal-title":"JAMA"},{"key":"BF03348960_CR15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0015-0282(16)48972-7","volume":"44","author":"P Serafini","year":"1985","unstructured":"Serafini P., Lobo R.A. The effects of spironolactone on adrenal steroidogenesis in hirsute women. Fertil. Steril. 44: 595, 1985.","journal-title":"Fertil. Steril."},{"key":"BF03348960_CR16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1210\/endo-97-1-52","volume":"97","author":"P Corvol","year":"1975","unstructured":"Corvol P., Michaud A., Menard J., Freifeld M., Mahoudeau J. Antiandrogenic effect of spirolactones: Mechanism of action. Endocrinology 97: 52, 1975.","journal-title":"Endocrinology"},{"key":"BF03348960_CR17","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1210\/endo-97-6-1521","volume":"97","author":"JC Pita","year":"1975","unstructured":"Pita J.C., Lippman M.E., Thompson E.B., Loriaux D.L. Interaction of spironolactone and digitalis with the 5\u03b1-dihydrotestosterone (DHT) receptor of rat ventral prostate. Endocrinology 97: 1521, 1975.","journal-title":"Endocrinology"},{"key":"BF03348960_CR18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1139\/o79-131","volume":"57","author":"A Boisselle","year":"1979","unstructured":"Boisselle A., Dionne F.T., Tremblay R.R. Interaction of spironolactone with rat skin androgen receptor. Can. J. Biochem. 57: 1042, 1979.","journal-title":"Can. J. Biochem."},{"key":"BF03348960_CR19","first-page":"338","volume":"460","author":"SM Rifka","year":"1977","unstructured":"Rifka S.M., Pita J.C., Vigersky R.A., Wilson Y.A., Loriaux D.L. Interaction of digitalis and spironolactone with human steroid receptors. J. Clin. Endocrinol. Metab. 460: 338, 1977.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348960_CR20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jcem-45-2-255","volume":"45","author":"R Caminos-Torres","year":"1977","unstructured":"Caminos-Torres R., Ma L., Snyder P.J. Gynecomastia and semen abnormalities induced by spironolactone in normal men. J. Clin. Endocrinol. Metab. 45: 255, 1977.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348960_CR21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/jcem-61-4-705","volume":"610","author":"A Manni","year":"1985","unstructured":"Manni A., Pardridge W.M., Cefalu W., Nisula B.C., Bardin C.W., Santner S.J., Santen R.J. Bioavailability of albumin-bound testosterone. J. Clin. Endocrinol. Metab. 610: 705, 1985.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348960_CR22","first-page":"476A","volume":"23","author":"DH Huffman","year":"1975","unstructured":"Huffman D.H., Azarnoff D.L. Effect of spironolactone on metabolic conversion of androgens to estrogens. A preliminary report [abstract]. Clin. Res. 23: 476A, 1975.","journal-title":"Clin. Res."},{"key":"BF03348960_CR23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/0003-4819-87-4-398","volume":"87","author":"LI Rose","year":"1977","unstructured":"Rose L.I., Underwood R.H., Newmark S.R., Kisch E.S., Williams G.H. Pathophysiology of spironolactone-induced gynecomastia. Ann. Intern. Med. 87: 398, 1977.","journal-title":"Ann. Intern. Med."},{"key":"BF03348960_CR24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0015-0282(16)44232-9","volume":"32","author":"A Boisselle","year":"1979","unstructured":"Boisselle A., Tremblay R.R. New therapeutic approach to the hirsute patient. Fertil. Steril. 32: 276, 1979.","journal-title":"Fertil. Steril."},{"key":"BF03348960_CR25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000136455","volume":"10","author":"DH Huffman","year":"1973","unstructured":"Huffman D.H., Shoeman D.W., Pentikainen P., Azarnoff D.L. The effect of spironolactone on antipyrine metabolism in man. Pharmacology 10: 338, 1973.","journal-title":"Pharmacology"},{"key":"BF03348960_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-4731(85)90236-5","volume":"23","author":"PC Serafini","year":"1985","unstructured":"Serafini P.C., Catalino J., Lobo R.A. The effect of spironolactone on genital skin 5\u03b1-reductase activity. J. Steroid Biochem. 23: 191, 1985.","journal-title":"J. Steroid Biochem."},{"key":"BF03348960_CR27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/jcem-47-3-691","volume":"47","author":"HP Schane","year":"1978","unstructured":"Schane H.P., Potts G.O. Oral progestational activity of spironolactone. J. Clin. Endocrinol. Metab. 47: 691, 1978.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348960_CR28","first-page":"1800","volume":"38","author":"Y Nishino","year":"1988","unstructured":"Nishino Y., Schroder H., El Etreby M.F. Experimental studies on the endocrine side effects of new aldosterone antagonists. Arzneimittel-Forschung 38: 1800, 1988.","journal-title":"Arzneimittel-Forschung"},{"key":"BF03348960_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2125.1983.tb01470.x","volume":"15","author":"MD Fernandez","year":"1983","unstructured":"Fernandez M.D., Carter G.D., Palmer T.N. The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol. Br. J. Clin. Pharmacol. 15: 95, 1983.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF03348960_CR30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1515\/DMDI.1987.5.4.273","volume":"5","author":"H Overdiek","year":"1987","unstructured":"Overdiek H., Merkus F. The metabolism and biopharmaceutics of spironolactone in man. Drug Metabol. Drug Interact. 5: 273, 1987.","journal-title":"Drug Metabol. Drug Interact."},{"key":"BF03348960_CR31","first-page":"52","volume":"24","author":"HA Skluth","year":"1990","unstructured":"Skluth H.A., Gums J.G. Spironolactone: A re-examination. D.I.C.P. 24: 52, 1990.","journal-title":"D.I.C.P."},{"key":"BF03348960_CR32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/j.1552-4604.1989.tb03339.x","volume":"290","author":"P Gardiner","year":"1989","unstructured":"Gardiner P., Schr\u00f6der K., Quinlan D., Martin B.K., Boreham D.R., Rogers M.S., Stubbs K., Smith M., Karim A. Spironolactone metabolism: Steady-state serum levels of the sulfur-containing metabolites. J. Clin. Pharmacol. 290: 342, 1989.","journal-title":"J. Clin. Pharmacol."},{"key":"BF03348960_CR33","first-page":"641","volume":"1","author":"G Lumb","year":"1978","unstructured":"Lumb G., Newberne P., Rust J.H., Wagner B. Effects in animals of chronic administration of spironolactone \u2014 A review. J. Environ. Pathol. Toxicol. 1: 641, 1978.","journal-title":"J. Environ. Pathol. Toxicol."},{"key":"BF03348960_CR34","first-page":"32","volume":"215","author":"A Hecker","year":"1978","unstructured":"Hecker A., Hasan S.H., Neumann F. Effect of spironolactone on the sexual differentiation of rat fetuses. Acta Endocrinol. (Copenh.) (Suppl.) 215: 32, 1978.","journal-title":"Acta Endocrinol. (Copenh.) (Suppl.)"},{"key":"BF03348960_CR35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0015-0282(16)48789-3","volume":"44","author":"RH Gorwill","year":"1985","unstructured":"Gorwill R.H., Steele H.D. Spironolactone: Is it safe in pregnancy? Evidence from the murine model. Fertil. Steril. (Abstract) 44: 68, 1985.","journal-title":"Fertil. Steril. (Abstract)"},{"key":"BF03348960_CR36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF03349319","volume":"2","author":"M Messina","year":"1979","unstructured":"Messina M., Biffignandi P., Ghigo E., Jeantet M.G., Molinatti G.M. Possible contraindication of spironolactone during pregnancy. [letter]. J. Endocrinol. Invest. 2: 222, 1979.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03348960_CR37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-89-5-643","volume":"89","author":"KP Ober","year":"1978","unstructured":"Ober K.P., Hennessy J.F. Spironolactone therapy for hirsutism in a hyperan-drogenic woman. Ann. Intern. Med. 89: 643, 1978.","journal-title":"Ann. Intern. Med."},{"key":"BF03348960_CR38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1210\/jcem-51-3-429","volume":"51","author":"G Shapiro","year":"1980","unstructured":"Shapiro G., Evron S. A novel use of spironolactone: Treatment of hirsutism. J. Clin. Endocrinol. Metab. 51: 429, 1980.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348960_CR39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(16)45795-X","volume":"36","author":"S Evron","year":"1981","unstructured":"Evron S., Shapiro G., Diamant Y.Z. Induction of ovulation with spironolactone (Aldactone) in anovulatory oligomenorrheic and hyperandrogenic women. Fertil. Steril. 36: 468, 1981.","journal-title":"Fertil. Steril."},{"key":"BF03348960_CR40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000249940","volume":"165","author":"PG Nielsen","year":"1982","unstructured":"Nielsen P.G. Treatment of idiopathic hirsutism with spironolactone. Dermatologica 165: 194, 1982.","journal-title":"Dermatologica"},{"key":"BF03348960_CR41","first-page":"429","volume":"61","author":"A Milewicz","year":"1983","unstructured":"Milewicz A., Silber D., Kirschner M.A. Therapeutic effects of spironolactone in polycystic ovary syndrome. Obstet. Gynecol. 61: 429, 1983.","journal-title":"Obstet. Gynecol."},{"key":"BF03348960_CR42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03350556","volume":"6","author":"M Messina","year":"1983","unstructured":"Messina M., Manieri C., Biffignandi P., Massucchetti C., Novi R.F., Molinatti G.M. Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism. J. Endocrinol. Invest. 6: 23, 1983.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03348960_CR43","first-page":"49","volume":"11","author":"P Spandri","year":"1984","unstructured":"Spandri P., Gangemi M., Nardelli G.B., Grandesso R., Ambrosio G.B., Gangemi M., Meneghetti G., De Salvia D., Predebon O. Testosterone, 17 KS, 17\u03b2E2, FSH-LH variations and hirsutism modifications during spironolactone therapy. Clin. Exp. Obstet. Gynecol. 11: 49, 1984.","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"BF03348960_CR44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0015-0282(16)48373-1","volume":"43","author":"RA S D Lobo","year":"1985","unstructured":"Lobo R.A. Shoupe D., Serafini P., Brinton D., Horton R. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil. Steril. 43: 200, 1985.","journal-title":"Fertil. Steril."},{"key":"BF03348960_CR45","doi-asserted-by":"crossref","unstructured":"Dorrington-Ward P., McCartney A.C.E., Holland S., Scully J., Carter G., Alaghband-Zadeh J., Wise P. The effect of spironolactone on hirsutism and female androgen metabolism. Clin. Endocrinol. 23: 161, 19850","DOI":"10.1111\/j.1365-2265.1985.tb00211.x"},{"key":"BF03348960_CR46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0300-595X(86)80030-5","volume":"15","author":"RR Tremblay","year":"1986","unstructured":"Tremblay R.R. Treatment of hirsutism with spironolactone. Endocrinol. Metab. Clin. North. Am. 15: 363, 1986.","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"BF03348960_CR47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/014107688607900806","volume":"79","author":"DJ Evans","year":"1986","unstructured":"Evans D.J., Burke C.W. Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome. J.R. Soc. Med. 79: 451, 1986.","journal-title":"J.R. Soc. Med."},{"key":"BF03348960_CR48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/00016348609157358","volume":"65","author":"MG Chapman","year":"1986","unstructured":"Chapman M.G., Katz M., Dowsett M., Hague W., Jeffcoate S.L., Dewhurst C.J. Spironolactone in the treatment of hirsutism. Acta Obstet. Gynecol. Scand. 65: 349, 1986.","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"BF03348960_CR49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02134038","volume":"240","author":"R Siegberg","year":"1987","unstructured":"Siegberg R., Ylostalo P., Laatikainen T., Pelkonen R., Stenman U. Endocrine and clinical effects of spironolactone in female hyperandrogenism. Arch. Gynecol. 240: 67, 1987.","journal-title":"Arch. Gynecol."},{"key":"BF03348960_CR50","first-page":"41","volume":"32","author":"P Ylostalo","year":"1987","unstructured":"Ylostalo P., Heikkinen A.r Kauppila A., Pakarinen A., Jarvinen P. Low-dose spironolactone in the treatment of female hirsutism. Int. J. Fertil. 32: 41, 1987.","journal-title":"Int. J. Fertil."},{"key":"BF03348960_CR51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02134041","volume":"240","author":"A Koksal","year":"1987","unstructured":"Koksal A., Pabuccu R., Akyurek C. Spironolactone in the treatment of hirsutism. Arch. Gynecol. 240: 95, 1987.","journal-title":"Arch. Gynecol."},{"key":"BF03348960_CR52","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1210\/jcem-68-5-966","volume":"68","author":"JA Barth","year":"1989","unstructured":"Barth J.A., Cherry C.A., Wojnarowska F., Dawber R.P.R. Spironolactone is an effective and well tolerated systemic antiandrogen therapy for hirsute women. J. Clin. Endocrinol. Metab. 68: 966, 1989.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348960_CR53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/pgmj.65.765.459","volume":"65","author":"AR McLellan","year":"1989","unstructured":"McLellan A.R., Rentoul J., MacKie R., Mclnnes G.T. Lack of effect of spironolactone on hair shaft diameter in hirsute females. Postgrad. Med. J. 65: 459, 1989.","journal-title":"Postgrad. Med. J."},{"key":"BF03348960_CR54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21: 144, 1961.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348960_CR55","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","volume":"140","author":"R Hatch","year":"1981","unstructured":"Hatch R., Rosenfield R.L., Kim M.H., Tredway D. Hirsutism: Implications, etiology, and management. Am. J. Obstet. Gynecol. 140: 815, 1981.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF03348960_CR56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/0003-4819-106-1-95","volume":"106","author":"RS Rittmaster","year":"1987","unstructured":"Rittmaster R.S., Loriaux D.L. Hirsutism. Ann. Intern. Med. 106: 95, 1987.","journal-title":"Ann. Intern. Med."},{"key":"BF03348960_CR57","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(64)91334-0","volume":"1","author":"JH Casey","year":"1964","unstructured":"Casey J.H., Moxham A., Nabarro J.D.N. Idiopathic hirsutism: Seasonal variation of hairgrowth and response to Oestrogen administration. Lancet 1: 587, 1964.","journal-title":"Lancet"},{"key":"BF03348960_CR58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/0003-4819-85-5-630","volume":"85","author":"DL Loriaux","year":"1976","unstructured":"Loriaux D.L., Menard R., Taylor A., Pita J.C., Santen R. Spironolactone and endocrine dysfunction. Ann. Intern. Med. 85: 630, 1976.","journal-title":"Ann. Intern. Med."},{"key":"BF03348960_CR59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1677\/joe.0.0840371","volume":"84","author":"J Levy","year":"1980","unstructured":"Levy J., Burshell A., Marbach M., Afllalo L., Glick S.M. Interaction of spironolactone with oestradiol receptors in cytosol. J. Endocrinol. 84: 371, 1980.","journal-title":"J. Endocrinol."},{"key":"BF03348960_CR60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0015-0282(16)60807-5","volume":"52","author":"ST Nakajima","year":"1989","unstructured":"Nakajima S.T., Brumsted J.R. Riddick D.H., Gibson M. Absence of progestational activity of oral spironolactone. Fertil. Steril. 52: 155, 1989.","journal-title":"Fertil. Steril."},{"key":"BF03348960_CR61","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/endo-97-2-366","volume":"97","author":"JP Louvet","year":"1975","unstructured":"Louvet J.P., Harman S.M., Schreiber J.R., Ross G.T. Evidence for a role of androgens in follicular maturation. Endocrinology 97: 366, 1975.","journal-title":"Endocrinology"},{"key":"BF03348960_CR62","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0015-0282(16)43945-2","volume":"31","author":"LJ Rodriguez-Rigau","year":"1979","unstructured":"Rodriguez-Rigau L.J., Steinberger E., Atkins B.J., Lucci J.A. Effect of testosterone on human corpus luteum steroidogenesis in vitro. Fertil. Steril. 31: 448, 1979.","journal-title":"Fertil. Steril."},{"key":"BF03348960_CR63","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/jcem-45-4-798","volume":"45","author":"DT Baird","year":"1977","unstructured":"Baird D.T., Corker C.S., Davidson D.W., Hunter W.M. Michie E.A., Van Look P.F.A. Pituitary-ovarian relationships in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 45: 798, 1977.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348960_CR64","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/00003081-199009000-00021","volume":"33","author":"JD Veldhuis","year":"1990","unstructured":"Veldhuis J.D. The hypothalamic pulse generator: The reproductive core. Clin. Obstet. Gynecol. 33: 538, 1990.","journal-title":"Clin. Obstet. Gynecol."},{"key":"BF03348960_CR65","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0022-4731(87)90107-5","volume":"260","author":"L Dehennin","year":"1987","unstructured":"Dehennin L., Jondet M., Scholler R. Androgen and 19-norsteroid profiles in human preovulatory follicles from stimulated cycles-An isotope dilution-mass spectrometric study. J. Steroid Biochem. 260: 399, 1987.","journal-title":"J. Steroid Biochem."},{"key":"BF03348960_CR66","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0022-4731(89)90488-3","volume":"33","author":"L Gooren","year":"1989","unstructured":"Gooren L. Androgens and estrogens in their negative feedback action in the hypothalamo-pituitary-testis axis: Site of action and evidence of their interaction. J. Steroid Biochem. 33: 757, 1989.","journal-title":"J. Steroid Biochem."},{"key":"BF03348960_CR67","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0015-0282(16)48615-2","volume":"43","author":"DE Pittaway","year":"1985","unstructured":"Pittaway D.E., Maxson W.S., Wentz A.C. Spironolactone in combination drug therapy for unresponsive hirsutism. Fertil. Steril. 43: 878, 1985.","journal-title":"Fertil. Steril."},{"key":"BF03348960_CR68","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jcem-72-5-1008","volume":"72","author":"RC O\u2019Brien","year":"1991","unstructured":"O\u2019Brien R.C., Cooper M.E., Murray R.M.L., Seeman E., Thomas A.K., Jerums G. Comparison of sequential cyproterone acetate\/estrogen versus spironolactone\/oral contraceptive in the treatment of hirsutism. J. Clin. Endocrinol. Metab. 72: 1008, 1991.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348960.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03348960\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T02:29:24Z","timestamp":1565317764000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03348960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,12]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1993,12]]}},"alternative-id":["BF03348960"],"URL":"https:\/\/doi.org\/10.1007\/bf03348960","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,12]]}}}